Video
Video
06/28/2024
James Matera, DO
In this video, James Matera, DO, discusses the management of patients with primary hyperoxaluria (PH), including dietary modifications, hepatic and/or kidney transplantation, RNA interference agents,...
06/28/2024
Video
Video
06/28/2024
James Matera, DO
In this video, James Matera, DO, discusses the management of patients with primary hyperoxaluria (PH), including dietary modifications, hepatic and/or kidney transplantation, RNA interference agents,...
06/28/2024
Video
Video
06/27/2024

Mirla Avila, MD

Mirla Avila, MD
In this video, Mirla Avila, MD, discusses how managing neuromyelitis optica disorder has evolved in the past decade, patient access to FDA-approved treatment options for neuromyelitis optica spectrum...
06/27/2024
Video
Video
06/27/2024

Mirla Avila, MD

Mirla Avila, MD
In this video, Mirla Avila, MD, discusses how managing neuromyelitis optica disorder has evolved in the past decade, patient access to FDA-approved treatment options for neuromyelitis optica spectrum...
06/27/2024
Video
Video
06/27/2024

Mirla Avila, MD

Mirla Avila, MD
In this video, Mirla Avila, MD, discusses how managing neuromyelitis optica disorder has evolved in the past decade, patient access to FDA-approved treatment options for neuromyelitis optica spectrum...
06/27/2024
Video
Video
06/27/2024

Mirla Avila, MD

Mirla Avila, MD
In this video, Mirla Avila, MD, discusses how managing neuromyelitis optica disorder has evolved in the past decade, patient access to FDA-approved treatment options for neuromyelitis optica spectrum...
06/27/2024
Video
Video
06/27/2024

Mirla Avila, MD

Mirla Avila, MD
In this video, Mirla Avila, MD, discusses how managing neuromyelitis optica disorder has evolved in the past decade, patient access to FDA-approved treatment options for neuromyelitis optica spectrum...
06/27/2024
Video
Video
06/27/2024

Mirla Avila, MD

Mirla Avila, MD
In this video, Mirla Avila, MD, discusses how managing neuromyelitis optica disorder has evolved in the past decade, patient access to FDA-approved treatment options for neuromyelitis optica spectrum...
06/27/2024
Video
Video
06/26/2024
James Matera, DO
In this video, James Matera, DO, discusses an overview of primary hyperoxaluria (PH), including genetic screening, the etiology and progression to end-stage kidney disease, incidence, and diagnosis of PH...
06/26/2024
Video
Video
06/26/2024
James Matera, DO
In this video, James Matera, DO, discusses an overview of primary hyperoxaluria (PH), including genetic screening, the etiology and progression to end-stage kidney disease, incidence, and diagnosis of PH...
06/26/2024